देश: संयुक्त राज्य
भाषा: अंग्रेज़ी
स्रोत: NLM (National Library of Medicine)
DEXAMETHASONE (UNII: 7S5I7G3JQL) (DEXAMETHASONE - UNII:7S5I7G3JQL)
Rebel Distributors Corp
DEXAMETHASONE
DEXAMETHASONE 1 mg
ORAL
PRESCRIPTION DRUG
Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (Stevens-Johnson syndrome). Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. To tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. Acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in a
1 mg yellow, scored tablets (Identified 54 489). NDC 21695-728-12: Bottles of 12 tablets. 2 mg white, scored tablets (Identified 54 662). NDC 21695-745-12: Bottles of 12 tablets. 4 mg green, scored tablets (Identified 54 892). NDC 21695-382-04: Bottles of 4 tablets. NDC 21695-382-08: Bottles of 8 tablets. NDC 21695-382-20: Bottles of 20 tablets. NDC 21695-382-60: Bottles of 60 tablets. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from moisture. Dispense in a well-closed, light-resistant container as defined in the USP/NF.
Abbreviated New Drug Application
DEXAMETHASONE- DEXAMETHASONE TABLET REBEL DISTRIBUTORS CORP ---------- DEXAMETHASONE TABLETS USP, RX ONLY DESCRIPTION Dexamethasone Tablets 0.5, 0.75, 1, 1.5, 2, 4 and 6 mg USP, Dexamethasone Oral Solution, 0.5 mg per 5 mL and Dexamethasone _Intensol_™ Oral Solution (Concentrate), 1 mg per mL are for oral administration. Each tablet contains: Dexamethasone 0.5, 0.75, 1, 1.5, 2, 4, or 6 mg Each 5 mL of Oral Solution contains: Dexamethasone....................................................... 0.5 mg Each mL of _Intensol_ ™ Oral Solution (Concentrate) contains: Dexamethasone....................................................... 1 mg Alcohol 30% INACTIVE INGREDIENTS The tablets contain lactose monohydrate, magnesium stearate, starch, sucrose, cosmetic ochre (1 mg), D&C Yellow No. 10 (0.5, 4 mg), FD&C Blue No. 1 (0.75, 1.5 mg), FD&C Green No. 3 (4, 6 mg), FD&C Red No. 3 (1.5 mg), FD&C Red No. 40 (1.5 mg), and FD&C Yellow No. 6 (0.5, 4 mg). The oral solution contains citric acid, disodium edetate, flavoring, glycerin, methylparaben, propylene glycol, propylparaben, sorbitol and water. The _Intensol_™ oral solution contains alcohol, benzoic acid, citric acid, disodium edetate, propylene glycol, and water. Dexamethasone, a synthetic adrenocortical steroid, is a white to practically white, odorless, crystalline powder. It is stable in air. It is practically insoluble in water. The molecular formula is C H FO . The molecular weight is 392.47. It is designated chemically as 9-fluoro-11β,17,21-trihydroxy-16α- methylpregna-1,4-diene,3,20-dione and the structural formula is: CLINICAL PHARMACOLOGY Glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. Glucocorticoids cause varied metabolic effects. In addition, they modify the body's immune responses to diverse stimuli. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have sodium-retaining properties, are used as replacement therapy in adrenocortical defi पूरा दस्तावेज़ पढ़ें